Skip to main navigation Skip to search Skip to main content

Machine learning competition in immunology – Prediction of HLA class I binding peptides

  • Guang Lan Zhang
  • , Hifzur Rahman Ansari
  • , Phil Bradley
  • , Gavin C. Cawley
  • , Tomer Hertz
  • , Xihao Hu
  • , Nebojsa Jojic
  • , Yohan Kim
  • , Oliver Kohlbacher
  • , Ole Lund
  • , Claus Lundegaard
  • , Craig A. Magaret
  • , Morten Nielsen
  • , Harris Papadopoulos
  • , G.P.S. Raghava
  • , Vider-Shalit Tal
  • , Li C. Xue
  • , Chen Yanover
  • , Shanfeng Zhu
  • , Michael T. Rock
  • James E. Crowe, Christos Panayiotou, Marios M. Polycarpou, Włodzisław Duch, Vladimir Brusic
    • Dana-Farber Cancer Institute
    • CSIR - Institute of Microbial Technology
    • Fred Hutchinson Cancer Research Center
    • University of East Anglia
    • Fudan University
    • Microsoft USA
    • La Jolla Institute for Allergy & Immunology
    • University of Tübingen
    • Frederick University
    • Bar-Ilan University
    • Iowa State University
    • Vanderbilt University
    • Nicolaus Copernicus University in Toruń
    • Nanyang Technological University
    • University of Cyprus

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Experimental studies of immune system and related applications such as characterization of immune responses against pathogens, vaccine design, or optimization of therapies are combinatorially complex, time-consuming and expensive. The main methods for large-scale identification of T-cell epitopes from pathogens or cancer proteomes involve either reverse immunology or high-throughput mass spectrometry (HTMS). Reverse immunology approaches involve pre-screening of proteomes by computational algorithms, followed by experimental validation of selected targets ( [Mora et al., 2006], [De Groot et al., 2008] and [Larsen et al., 2010]). HTMS involves HLA typing, immunoaffinity chromatography of HLA molecules, HLA extraction, and chromatography combined with tandem mass spectrometry, followed by the application of computational algorithms for peptide characterization (Bassani-Sternberg et al., 2010). Hundreds of naturally processed HLA class I associated peptides have been identified in individual studies using HTMS in normal (Escobar et al., 2008), cancer ( [Antwi et al., 2009] and [Bassani-Sternberg et al., 2010]), autoimmunity-related (Ben Dror et al., 2010), and infected samples (Wahl et al, 2010). Computational algorithms are essential steps in high-throughput identification of T-cell epitope candidates using both reverse immunology and HTMS approaches. Peptide binding to MHC molecules is the single most selective step in defining T cell epitope and the accuracy of computational algorithms for prediction of peptide binding, therefore, determines the accuracy of the overall method. Computational predictions of peptide binding to HLA, both class I and class II, use a variety of algorithms ranging from binding motifs to advanced machine learning techniques ( [Brusic et al., 2004] and [Lafuente and Reche, 2009]) and standards for their assessments have been developed. The assessments of computational servers that predict peptide binding to several common HLA class I alleles have been performed by different groups (see [Peters et al., 2006], [Lin et al., 2008] and [Gowthaman et al., 2010]). Some of these models were reported to be highly accurate while others need improvement.
    Original languageEnglish
    JournalJournal of Immunological Methods
    Volume374
    Issue number1-2
    Pages (from-to)1-4
    ISSN0022-1759
    DOIs
    Publication statusPublished - 2011

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Computational models
    • Peptide binding
    • Human leukocyte antigen
    • HLA
    • Predictions
    • Machine learning

    Fingerprint

    Dive into the research topics of 'Machine learning competition in immunology – Prediction of HLA class I binding peptides'. Together they form a unique fingerprint.

    Cite this